Immunome IMNM - 옵션 체인 | ADVFN

다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

Immunome Inc (IMNM)

10.76

-0.44

(-3.93%)

종가: 08 1월 6:00AM

11.10

0.34

( 3.16% )

시간외 거래: 6:32AM

IMNM 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	4.10	8.50	0.00	6.30	0.00	0.00 %	0	0	-
7.50	1.75	5.90	4.40	3.825	0.00	0.00 %	0	2	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.20	0.75	0.15	0.475	-0.25	-62.50 %	9	1,312	02:52:54
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.05	0.05	0.05	0.05	0.00	0.00 %	0	234	-
22.50	0.30	0.05	0.30	0.175	0.00	0.00 %	0	31	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.20	2.50	1.50	1.35	-0.30	-16.67 %	1	81	00:13:55
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	9.00	13.30	0.00	11.15	0.00	0.00 %	0	0	-
25.00	11.50	16.00	0.00	13.75	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SANASana Biotechnology Inc	US$ 6.0699 (267.87%)	20.12M
SFWLShengfeng Development Ltd	US$ 1.42 (32.71%)	596.46k
JBDIJBDI Holdings Ltd	US$ 0.9299 (31.34%)	4.96M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.15 (30.43%)	23.54M
IPSCCentury Therapeutics Inc	US$ 1.23 (16.04%)	227.28k
XTIAXTI Aerospace Inc	US$ 0.0609 (-46.63%)	188.86M
DRIODarioHealth Corporation	US$ 1.0401 (-32.02%)	320.31k
ALKTAlkami Technology Inc	US$ 25.50 (-27.91%)	13.74k
AREBAmerican Rebel Holdings Inc	US$ 2.10 (-24.73%)	623.4k
ENVBEnveric Biosciences Inc	US$ 0.3976 (-21.25%)	535.56k
XTIAXTI Aerospace Inc	US$ 0.0607 (-46.80%)	188.85M
SVMHSRIVARU Holding Ltd	US$ 0.0699 (-16.79%)	57.39M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.148 (28.70%)	23.59M
SANASana Biotechnology Inc	US$ 6.05 (266.67%)	20.13M
CEROCERo Therapeutics Holdings Inc	US$ 0.0487 (-6.88%)	7.36M

tw0122

tw0122 1 월 전

Looking good in some reverse head and shoulders at .85+4% and .92-.99 up next. The world of DNA

Monksdream

Monksdream 4 월 전

Monksdream

Monksdream 10 월 전

IMNM 10Q due 3/22

Monksdream

Monksdream 10 월 전

IMNM new 52 week hi

Monksdream

Monksdream 12 월 전

IMNM new 52 week high

OncoJock

OncoJock 1 년 전

Agree.

Wish there were most posts on this board.

Wondering who might be the next big customer to sign a major discovery and commercialization contract with IMNM, after AbbVie?

Also wondering if IMNM is doing any discovery/testing/research related to bispecific antibodies, as opposed to antibody-drug conjugates. Bispecifics are HOT HOT HOT in lymphoma and myeloma.

-- OJ

OncoJock

OncoJock 1 년 전

Laster

Laster 1 년 전

Hopefully the vote passed.
I think this biotech combined company can be a huge success.
Siegall has proven he can build a biotech company.
This will be fun to watch.

Laster

Laster 1 년 전

I believe merger news tomorrow along with huge financing.
Clay B. Siegall To become chairman and CEO of combined company.
He founded Seagen which just sold for $40 billion to Pfizer.
Their innovative technology from Professor Philip S. Low (Purdue University).
Look at Professor Low accomplishments. Unreal.
Watching closely because this might become a huge biotech company.

wiwineguy

wiwineguy 2 년 전

Ha, sold in fall of 21 for $25.

makinezmoney

makinezmoney 2 년 전

$IMNM: Now 10.40 !!!!!!!!!!!

Booooooooooooyakashaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies

GO $IMNM

makinezmoney

makinezmoney 2 년 전

$IMNM: Boooommmmmmmmmmmmmmm.......now $8.50

Offfffffffffff she goes.

Nice boomer

GO $IMNM

Awl416

Awl416 2 년 전

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies

wiwineguy

wiwineguy 3 년 전

you don't know crap majorbankz. you keep saying i "heard" this, and I "heard" that. can you be any more vague. stfu

Harbor6460

Harbor6460 3 년 전

They cannot dilute on the bid. Only the ask

Pedro2004

Pedro2004 3 년 전

Pulled down to under $20.00

Pedro2004

Pedro2004 3 년 전

They pulled this down to under $21.00

I'm back-in at $21.00

Major_Bankz

Major_Bankz 3 년 전

$22.50 U worry too much, should be $25+ this afternoon IMO

Pedro2004

Pedro2004 3 년 전

I thought this was going to break today. But it' just jumped over $22 -- let's see if that holds.

Pedro2004

Pedro2004 3 년 전

This run could have broke $30 today. But the company killed-it.

Major_Bankz

Major_Bankz 3 년 전

yep, shorties portfolio will get destroyed here.

Pedro2004

Pedro2004 3 년 전

The dilution is going to kill this run.

Pedro2004

Pedro2004 3 년 전

Looks like the company is dumping shares on the bid.

Major_Bankz

Major_Bankz 3 년 전

I don't think PFE and MRNA can claim the same effectiveness for DELTA, plus time to buy is during development not after just like when MRNA was at $20. IMO

Major_Bankz

Major_Bankz 3 년 전

Delta is a BIG problem, IMNM may catch up to PFE and MRNA. IMO

Major_Bankz

Major_Bankz 3 년 전

Immunome was awarded a $17.6 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency, to support Immunome’s COVID program.

Given the near-term potential for a resurgence of COVID-19 infections driven by emerging variants, Immunome intends to explore opportunities to expedite the development of this potential therapeutic. The Company plans to submit an IND application with the U.S. Food and Drug Administration (FDA) this quarter.

Major_Bankz

Major_Bankz 3 년 전

IMNM $21 Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관